Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Cook

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Merging regulatory and reimbursement needs in clinical trialsJohn R Cook
Pharmacoeconomics|January 27, 2005
Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemiaJohn R Cook, Don Yin, Evo Alemao, et al.
Medical Hypotheses|November 4, 2019
Proposed symptom-based model of the origins of schizophreniaJohn R Cook, Steven M Platek, Carlos N Espinoza
BMC Health Services Research|March 18, 2023
Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in IndiaJohn R Cook, Kunal Saxena, Catharine Taylor, et al.
Statistics in Medicine|June 13, 2003
Assessing the appropriateness of combining economic data from multinational clinical trialsJohn R Cook, Michael Drummond, Henry Glick, et al.
Advances in Experimental Medicine and Biology|February 9, 2022
SARS/CoV-2: Behavioral Host ManipulationJohn R Cook, Kaylee V Bennett, Michael C Barton, et al.
Atherosclerosis|March 22, 2005
Projected coronary heart disease risk benefit with ezetimibeGlenn M Davies, John R Cook, John Erbey, et al.
Clinical Therapeutics|August 19, 2007
Cholesterol reduction yields clinical benefits: meta-analysis including recent trialsA Lawrence Gould, Glenn M Davies, Evo Alemao, et al.
Medical Hypotheses|May 11, 2020
Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infectionMichael C Barton, Kaylee V Bennett, John R Cook, et al.
Journal of Medical Economics|September 17, 2011
Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in TaiwanRobbin F Itzler, Po Yen Chen, Christina Lac, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Merging regulatory and reimbursement needs in clinical trialsJohn R Cook
Pharmacoeconomics|January 27, 2005
Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemiaJohn R Cook, Don Yin, Evo Alemao, et al.
Medical Hypotheses|November 4, 2019
Proposed symptom-based model of the origins of schizophreniaJohn R Cook, Steven M Platek, Carlos N Espinoza
BMC Health Services Research|March 18, 2023
Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in IndiaJohn R Cook, Kunal Saxena, Catharine Taylor, et al.
Statistics in Medicine|June 13, 2003
Assessing the appropriateness of combining economic data from multinational clinical trialsJohn R Cook, Michael Drummond, Henry Glick, et al.
Advances in Experimental Medicine and Biology|February 9, 2022
SARS/CoV-2: Behavioral Host ManipulationJohn R Cook, Kaylee V Bennett, Michael C Barton, et al.
Atherosclerosis|March 22, 2005
Projected coronary heart disease risk benefit with ezetimibeGlenn M Davies, John R Cook, John Erbey, et al.
Clinical Therapeutics|August 19, 2007
Cholesterol reduction yields clinical benefits: meta-analysis including recent trialsA Lawrence Gould, Glenn M Davies, Evo Alemao, et al.
Medical Hypotheses|May 11, 2020
Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infectionMichael C Barton, Kaylee V Bennett, John R Cook, et al.
Journal of Medical Economics|September 17, 2011
Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in TaiwanRobbin F Itzler, Po Yen Chen, Christina Lac, et al.
Pageof 2